Clinical trial
Post-Market Clinical Follow-up Registry to Evaluate the Safety and Performance of the Atrium Advanta VXT and Flixene Vascular Grafts in Patients Undergoing Surgical Repair or Replacement of Peripheral Arteries
NCT07161583 is registered in ClinicalTrials.gov with Atrium Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Market Clinical Follow-up Registry to Evaluate the Safety and Performance of the Atrium Advanta VXT and Flixene Vascular Grafts in Patients Undergoing Surgical Repair or Replacement of Peripheral Arteries
- Lead sponsor
- Atrium Medical Corporation
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 25, 2025
- Completion date
- December 31, 2027
- Enrollment
- 1,000 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.